Is the addition of a polyol to hyaluronic acid a significant advance in the treatment of osteoarthritis? Conrozier T. Curr Rheumatol Rev. 2017 Jul 10. doi:10.2174/1573397113666170710115558. Viscosupplementation with intra-articular injections of hyaluronic acid is recommended as a second line treatment for knee OA, after failure of non-pharmacological modalities and usual Read more…
LABRHA participated at the EULAR Congress, which took place from the 14th to the 17th of June 2017 in Madrid, and presented the very positive results of a study conducted on its product Fibromyalgine®, a phytotherapy solution designed for Fibromyalgia sufferers. The abstract MULTICENTER, PROSPECTIVE, CONTROLLED DOUBLE-BLIND STUDY COMPARING FIB-19-01 Read more…
Safety and Efficacy of Single Intra-Articular Injection of a Cross-Linked Hyaluronic Acid/Mannitol Formulation [Happycross®] in knee Osteoarthritis Results of a Prospective Observational Study in Daily Practice Conditions. Monet M, Bozgan AM, Conrozier T. Ortho & Rheum Open Access 2017; 5(3): 555664. DOI: 10.19080/OROAJ.2017.05.555664. . This study has been conducted to Read more…
LABRHA participated at the OARSI 2017 World Congress which took place from the 27th to the 30th of April 2017 in Las Vegas. . 1) HAppyMini® in the Trapeziometacarpal joint: first results presented at the OARSI Congress . The abstract SAFETY AND EFFICACY OF A SINGLE INJECTION OF MANNITOL-MODIFIED CROSSLINKED Read more…
LABRHA is supporting Eurovisco by organizing its annual board since 2014. We are proud to be Eurovisco’s partner. Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis. Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).R. Raman, Y. Henrotin, X. Chevalier, A. Migliore, J. Jerosch, J. Montfort, H. Read more…